Literature DB >> 30704853

Clinical and anatomical predictors for freezing of gait and falls after subthalamic deep brain stimulation in Parkinson's disease patients.

Carine Karachi1, Florence Cormier-Dequaire2, David Grabli2, Brian Lau3, Hayat Belaid1, Soledad Navarro4, Marie Vidailhet2, Eric Bardinet5, Sara Fernandez-Vidal5, Marie-Laure Welter6.   

Abstract

INTRODUCTION: Freezing of gait (FOG) and falls are the most disabling motor symptoms in Parkinson's disease (PD) patients. The effects of subthalamic deep-brain-stimulation (STN-DBS) on FOG and falls are still a matter of controversy, and factors contributing to their outcome have yet to be defined.
METHODS: We examined the relationship between FOG and falls after STN-DBS and preoperative clinical features, MRI voxel-based-morphometry (VBM) analysis and statistical mapping of electrode locations.
RESULTS: 331 patients (age at surgery = 57.7 ± 8.4 years; disease duration = 12.5 ± 5 years) were included in the final analysis, with VBM analysis in 151 patients. After surgery, FOG was aggravated in 93 patients and falls in 75 patients. After surgery, FOG severity was related to its level before surgery without dopaminergic treatment, the dopaminergic treatment dosage and severity of motor fluctuations after surgery; and falls severity to lower postoperative cognitive performance. VBM analyses revealed that, relative to other patient groups, patients with FOG worsening had putamen grey matter density decrease, and fallers patients a left postcentral gyrus atrophy. The best effects of STN-DBS on FOG and falls were associated with the location of contacts within the STN, but no specific location related to aggravation.
CONCLUSIONS: FOG and falls are reduced after STN-DBS in about 1/3 of patients, with the best effects obtained for electrodes located within the STN. Clinicians should be aware that, after STN-DBS, FOG severity is related to preoperative FOG severity whatever its dopa-sensitivity; and falls to lower postoperative cognitive performance; and atrophy of cortico-subcortical brain areas.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Deep brain stimulation; Falls; Freezing of gait; Parkinson's disease; Subthalamic nucleus

Mesh:

Substances:

Year:  2019        PMID: 30704853     DOI: 10.1016/j.parkreldis.2019.01.021

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  5 in total

Review 1.  Freezing of gait: understanding the complexity of an enigmatic phenomenon.

Authors:  Daniel Weiss; Anna Schoellmann; Michael D Fox; Nicolaas I Bohnen; Stewart A Factor; Alice Nieuwboer; Mark Hallett; Simon J G Lewis
Journal:  Brain       Date:  2020-01-01       Impact factor: 13.501

2.  Clinical and Kinematic Correlates of Favorable Gait Outcomes From Subthalamic Stimulation.

Authors:  Idil Cebi; Marlieke Scholten; Alireza Gharabaghi; Daniel Weiss
Journal:  Front Neurol       Date:  2020-04-22       Impact factor: 4.003

Review 3.  A systematic review of brain morphometry related to deep brain stimulation outcome in Parkinson's disease.

Authors:  Fengting Wang; Yijie Lai; Yixin Pan; Hongyang Li; Qimin Liu; Bomin Sun
Journal:  NPJ Parkinsons Dis       Date:  2022-10-13

4.  Clinical parameters predict the effect of bilateral subthalamic stimulation on dynamic balance parameters during gait in Parkinson's disease.

Authors:  Andrea Kelemen; László Halász; Muthuraman Muthuraman; Loránd Erőss; Péter Barsi; Dénes Zádori; Bence Laczó; Dávid Kis; Péter Klivényi; Gábor Fekete; László Bognár; Dániel Bereczki; Gertrúd Tamás
Journal:  Front Neurol       Date:  2022-09-26       Impact factor: 4.086

5.  Axial impairment and falls in Parkinson's disease: 15 years of subthalamic deep brain stimulation.

Authors:  Alessandro Zampogna; Francesco Cavallieri; Francesco Bove; Antonio Suppa; Anna Castrioto; Sara Meoni; Pierre Pélissier; Emmanuelle Schmitt; Amélie Bichon; Eugénie Lhommée; Andrea Kistner; Stephan Chabardès; Eric Seigneuret; Valerie Fraix; Elena Moro
Journal:  NPJ Parkinsons Dis       Date:  2022-09-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.